Related Experiment Video

Updated: Aug 11, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Use of cardiac markers as assessed by outcomes analysis

A H Wu1

  • 1Department of Pathology and Laboratory Medicine, Hartford Hospital, CT 06102, USA. awu@harthosp.org

Clinical Biochemistry
|June 1, 1997
PubMed

Insights

Biochemical markers aid in diagnosing acute myocardial infarction (AMI) and managing coronary artery disease (CAD). Further research is needed to optimize cardiac marker use for improved patient outcomes and cost-effectiveness.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Coronary artery disease (CAD) diagnosis relies heavily on biochemical markers.
  • Effective utilization of these markers can significantly impact patient management and healthcare costs.

Purpose of the Study:

  • To review existing outcome studies on biochemical markers in CAD.
  • To identify areas where further research is needed for biochemical markers in CAD.

Main Methods:

  • Review of studies on emergency department chest pain centers and cardiac markers.
  • Analysis of cardiac marker testing frequency's impact on length of stay (LOS).
  • Evaluation of troponin T and I for risk stratification in unstable angina (UA).
  • Assessment of serum markers for thrombolytic therapy success post-acute myocardial infarction (AMI) and rescue percutaneous transluminal coronary angioplasty (PTCA).
  • Discussion on the need and criteria for implementing new cardiac tests.

Main Results:

  • Chest pain centers reduce unnecessary admissions and costs for AMI rule-outs.
  • Stat testing of cardiac markers reduces hospital LOS for AMI patients.
  • Serial myoglobin measurements can indicate successful reperfusion.
  • New markers are needed for early diagnosis and to assess early pathophysiologic events in AMI.

Conclusions:

  • Optimizing the use of biochemical markers in CAD management is crucial.
  • Further studies are required to refine risk stratification and treatment strategies for UA patients.
  • Development of novel biomarkers for early AMI detection and pathophysiological event assessment holds significant promise.
Abstract

More Related Videos

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...